flufenamic acid has been researched along with Drug-Induced Stevens Johnson Syndrome in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is the first case of toxic epidermal necrolysis because of treatment with etofenamate of which we are aware." | 1.36 | Etofenamate associated with Lyell syndrome: a case report. ( Atilla, OD; Golcuk, Y; Oray, D; Tefennioglu, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golcuk, Y | 1 |
| Oray, D | 1 |
| Atilla, OD | 1 |
| Tefennioglu, N | 1 |
1 other study available for flufenamic acid and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Etofenamate associated with Lyell syndrome: a case report.
Topics: Awareness; Female; Flufenamic Acid; Humans; Middle Aged; Risk Factors; Stevens-Johnson Syndrome | 2010 |